NCT06904339 Communication About Sexual Health in Gynecologic Cancer
| NCT ID | NCT06904339 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fox Chase Cancer Center |
| Condition | Gynecologic Cancers |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-02-20 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-02-20 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an educational video and workbook can help gynecologic cancer patients talk to their cancer providers about sexual health concerns. The main questions it aims to answer are: 1. Do gynecologic cancer patients who take part in the educational program and get a resource booklet talk to their cancer clinicians more about sexual health concerns than patients who get a resource booklet alone? 2. Do gynecologic cancer patients who take part in the educational program and get a resource booklet have better sexual function and less anxiety and depression than patients who get a resource booklet alone? Researchers will compare those who get the educational program and the resource booklet to those who get the resource booklet alone along with their usual care. Participants will: 1. Fill out a consent form and survey 2. Have their next clinic visit audio recorded 3. Fill out another survey right after their clinic visit 4. Fill out a final survey 6 months after their clinic visit
Eligibility Criteria
Inclusion Criteria: * At least 18 years old * Diagnosed with any stage (I-IV) gynecologic cancer * Receiving treatment for gynecologic cancer or completed active treatment less than 10 years ago * Attending visits in follow-up care at Fox Chase Cancer Center * Score of at least 3 on a sexual concerns screener question Exclusion Criteria: * Not able to speak English * Not willing to have clinic visit audio recorded * Eastern Cooperative Oncology Group (ECOG) score \> 2 * Overt cognitive dysfunction or psychiatric disturbance
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06904339 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06904339 currently recruiting?
Yes, NCT06904339 is actively recruiting participants. Contact the research team at jennifer.reese@fccc.edu for enrollment information.
Where is the NCT06904339 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06904339 clinical trial?
NCT06904339 is sponsored by Fox Chase Cancer Center. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.